Ablynx

URI: https://gptkb.org/entity/Ablynx
GPTKB entity
Statements (25)
Predicate Object
gptkbp:instanceOf gptkb:biotechnology
gptkbp:acquiredBy gptkb:Sanofi
gptkbp:acquisitionYear 2018
gptkbp:country gptkb:Belgium
gptkbp:focusesOn nanobody-based therapeutics
gptkbp:foundedIn 2001
gptkbp:founder gptkb:Raymond_Hamers
gptkb:Serge_Muyldermans
gptkb:Vlaams_Instituut_voor_Biotechnologie
gptkbp:headquartersLocation gptkb:Ghent,_Belgium
https://www.w3.org/2000/01/rdf-schema#label Ablynx
gptkbp:industry gptkb:biotechnology
gptkbp:notableEmployee gptkb:Edwin_Moses
gptkbp:notableProduct gptkb:Caplacizumab
gptkbp:parentCompany gptkb:Sanofi
gptkbp:product gptkb:Caplacizumab
gptkbp:researchInterest immunology
hematology
rare diseases
gptkbp:stockExchange gptkb:Euronext_Brussels
gptkbp:stockSymbol gptkb:ABLX
gptkbp:website https://www.ablynx.com/
gptkbp:bfsParent gptkb:Sanofi-Aventis
gptkb:赛诺菲
gptkbp:bfsLayer 6